A novel atopic dermatitis model induced by topical application with Dermatophagoides farinae extract in NC/Nga mice

Allergology International

Volumn 56, Issue 2, 2007, Pages 139-148

  Yamamoto, Mina ^a   Haruna, Takayo ^a   Yasui, Kiyoshi ^a   Takahashi, Hisashi ^b   Iduhara, Miho ^b   Takaki, Shigeki ^b   Deguchi, Masashi ^a   Arimura, Akinori ^a  

^a SHIONOGI AND CO LTD   (Japan)

^b Fumakilla Ltd   (Japan)

Author keywords

Animal model; Atopic dermatitis; Dermatophagoides farinae; House dust mite; Nc Nga mice

Indexed keywords

BETAMETHASONE DIPROPIONATE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INSECT PROTEIN; INTERLEUKIN 13; INTERLEUKIN 5; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CLINICAL FEATURE; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; DISEASE COURSE; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SKIN DEFECT;

EID: 34250890135     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-06-458     Document Type: Article

References (25)

1. Schultz-Larsen F, Hanifin JM. Epidemiology of atopic dermatitis. Immunol. Allergy Clin. North Am. 2002;22:1-24.
2. Furue M, Terao H, Moroi Y et al. Dosage and adverse effects of topical tacrolimus and steroids in daily management of atopic dermatitis. J. Dermatol. 2004;31:277-283.
3. Matsuda H, Watanabe N, Gregory PG et al. Development of atopic dermatitis-like skin lesion with hyperproduction in NC/Nga mice. Int. Immunol. 1996;9:461-466.
4. Morita E, Kaneko S, Hiragun T et al. Fur mites induce dermatitis associated with IgE hyperproduction in an inbred strain of mice, NC/Kuj. J. Dermatol. Sci. 1999;19:37-43.
5. Iijima OT, Takeda H, Komatsu Y, Matsumiya T, Takahashi H. Atopic dermatitis in NC/Jic mice associated with Myobia musculi infestation. Comp. Med. 2000;50:225-228.
6. Okada M, Hirasawa Y, Yoshijima K et al. Effect of clobetasol propionate, a corticosteroid on hapten-induced dermatitis in SPF NC/Nga mice. Pharmacometrics 2000;59:135-139.
7. Makiura M, Akamatsu H, Akita H et al. Atopic dermatitis-like symptoms in HR-1 hairless mice fed a diet low in magnesium and zinc. J. Int. Med. Res. 2004;32:392-399.
8. Holm L, van Hage-Hamsten M, Ohman S, Scheynius A Sensitization to allergens of house-dust mite in adults with atopic dermatitis in a cold temperate region. Allergy 1999;54:708-715.
9. Sanda T, Yasue T, Oohashi M, Yasue A. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J. Allergy Clin. Immunol. 1992;89:653-657.
10. Katoh N, Hirano S, Suehiro M, Matsuda K, Kishimoto S. The characteristics of patients with atopic dermatitis demonstrating a positive reaction in a scratch test after 48 hours against house dust mite antigen. J. Dermatol. 2004; 31:720-726.
11. Matsuoka H, Maeda N, Atsuta Y, Ando K, Chinzei Y. Seasonal fluctuations of Dermatophagoides mite population in house dust Jpn. J. Med. Sci. Biol. 1995;48:103-115.
12. Matsuoka H, Maki N, Yoshida S et al. A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae. Allergy 2003;58:139-145.
13. Sasa M, Miyamoto J, Shinohara S, Suzuki H, Katsuhata A. Studies on mass culture and isolation of Dermatophagoides farinae and some other mites associated with house dust and stored food. Jpn. J. Exp. Med. 1970;40:367-382.
14. Yamaguchi T, Ono K, Shigeta S et al. Differences in response of patient's blood cells with bronchial asthma to diverse house dust mite allergens by histamine release assay. Jpn. J. Allergol. 1993;42:1754-1763.
15. Mota I, Wong D. Homologous and heterologous passive cutaneous anaphylactic activity of mouse antisera during the course of immunization. Life Sci. 1969;8:813-820.
16. Leung DYM, Bieber T. Atopic dermatitis. Lancet 2003; 361:151-160.
17. Kang K, Stevens SR. Pathophysiology of atopic dermatitis. Clin. Dermatol. 2003;21:116-121.
18. Hamid Q, Boguniewicz M, Leung DYM. Diffential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J. Clin. Invest. 1994;94:870-876.
19. Ohmen JD, Hanifin JM, Nickoloff BJ et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J. Immunol. 1995;154:1956-1963.
20. Klunker S, Trautmann A Akdis M et al. A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis. J. Immunol. 2003;171:1078-1084.
21. Leung DY, Boguniewicz M, Howell MD et al. New insights into atopic dermatitis. J. Clin. Invest. 2004;113:651-657.
22. Wahlgren CF. Itch and atopic dermatitis: an overview. J. Dermatol. 1999;26:770-779.
23. Ellis C, Luger T, Abeck D et al. International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies. Br. J. Dermatol. 2003;63:3-10.
24. Katoh N, Hirano S, Yasuno H, Kishimoto S. Effects of tacrolimus ointment on facial eruption, itch, and scratch in patients with atopic dermatitis. J. Dermatol. 2004;31: 194-199.
25. Hiroi J, Sengoku T, Morita K et al. Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice. Jpn. J. Pharmacol. 1998;76:175-183.